BioMarin Pharmaceutical (BMRN)

55.01

+0.22 (+0.40%)

Range	54.65 - 55.25
52 week	31.91 - 56.71
Open	55.01
Vol/Avg.	1,042,610

Mkt cap	6.812B
P/E	-
EPS	-0.748
Book/share	8.201

Short ratio	10.40
PEG	-
EPS est.	-0.22

Rare webinar exposes 1 new law that will kill
your wealth in 2013 unless you take action now...

BMRN additional information

Loading ...

Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.

Trading Offers • Rare webinar exposes 1 new law that will kill your wealth in 2013 unless you take action now...		Special Offers • Download a free Options Fundamentals Podcast, from The Options Industry Council.

BMRN Profile

•

Exchange

NASDAQ

•

Sector

Healthcare

•

Industry

Biotechnology

•

Top Holders (By Fund)

Vanguard Capital Opportunity Inv
Vanguard Capital Opportunity Adm
iShares Nasdaq Biotechnology
Prudential Jennison Health Sciences Z
Prudential Jennison Health Sciences C
Prudential Jennison Health Sciences B
Prudential Jennison Health Sciences A
Invesco Global Health Care Invstor
Invesco Global Health Care A
Invesco Global Health Care Y

•

Top Holders (By Family)

Vanguard
Invesco
Prudential Investments
Janus
iShares
Fidelity Investments
State Street Global Advisors
Touchstone

•

Competitors

Medicis Pharmaceutical
Protalix BioTherapeutics
Amicus Therapeutics
Shire plc

•

Executives

Mr. Jean-Jacques Bienaim
Chief Exec. Officer and Director

Mr. Stephen Aselage
Chief Bus. Officer and Exec. VP

Dr. Henry J. Fuchs M.D. .D.
54
Chief Medical Officer and Exec. VP
Dr. Robert A. Baffi Ph.D.
Exec. VP of Technical Operations

Mr. Jeffrey H. Cooper CPA
Advisor

•

Index Membership

NASDAQ Composite
NASDAQ Biotechnology

•

Employee Count

1,002